CellMed 2024; 14(9): 2.1-2.4
Published online July 31, 2024
https://doi.org/10.5667/CellMed.spc.089
© Cellmed Orthocellular Medicine and Pharmaceutical Association
조종빈 약사
전라남도 화순군 화순읍 자치샘로 42-2 셀메드화순종로약국
Correspondence to : Jong-Bin Jo
E-mail: jongro3720178@hanmail.net
☨ This report has been translated and edited by the CellMed editor-in-chief, Prof. Beom-Jin Lee.
This is an open access article under the CC BY-NC license. (http://creativecommons.org/licenses/by-nc/3.0/)
Objective: A case report on the improvement of xerotic eczema through Ortho-Cellular Nutrition Therapy (OCNT).
Methods: OCNT was administered to Korean women in their 60s and 70s who had been experiencing xerotic eczema for several years to decades.
Results: After the application of OCNT, there was a significant improvement in the symptoms of xerotic eczema and individual symptoms the patients had.
Conclusion: The application of OCNT can help alleviate symptoms in patients with xerotic eczema.
Keywords Ortho-Cellular Nutrition Therapy (OCNT), xerotic eczema, frostbite, cold environments
Xerotic eczema refers to eczema that occurs when the skin is dry. This symptom often occurs between autumn and spring, especially during the mostly dry winter season, hence it is also called "winter eczema." It occurs frequently in young people but is predominantly found in the elderly.1
The symptoms of xerotic eczema include dryness, skin cracking, excessive scaling, redness, erythema, pain, etc. Scales, in this case, may cause the dry skin to rise like 'cracked pottery' or 'a dry riverbed'.2 Occasionally, the skin may thicken or hyperpigmentation may occur. These symptoms mainly develop on the arms and legs, particularly the shins, and also frequently occur on exposed areas such as the nose, ears, and face.
Xerotic eczema is often caused by decreased lipids on the surface of the skin consisting of the lipid layer, dermis, and epidermis or by functional skin disorders. In such cases, increased moisture loss through the epidermis from the stratum corneum decreases the skin's moisture content. This situation causes the epidermis to contract and leads to excessive scaling and itching.3
These symptoms can occur when exposed to cold and dry environments for extended periods. Conversely, they can be exacerbated by using too hot water and harsh cleansers for showering or bathing without moisturizing afterward.1 Therefore, it is crucial to reduce behaviors that may irritate the skin and to manage humidity and moisturize using oily lotions.4
Despite these preventive measures, when xerotic eczema does occur, it can be treated with oral medications, topical steroids, and antihistamines.4 However, most treatments rely on symptomatic relief, and prolonged use of steroids can lead to increased infection risks, skin atrophy, and delayed wound healing, necessitating caution in their prescription and use.5
This case study targeted two patients who had long-standing xerotic eczema and exhibited significant improvement of symptoms following Ortho-Cellular Nutrition Therapy (OCNT).
Two cases of xerotic eczema, referred to as Patient A and Patient B.
- Patient A
1) Name: Jung O (F/61)
2) Diagnosis: Xerotic eczema, dry skin
3) Date of Onset: Several years ago
4) Treatment Duration: February 2022 ~ June 2022
5) Primary Symptoms: Cracking on the backs of the hands, thinning facial skin, dryness in the ears, leg numbness, dizziness
6) Medical history: Frostbite, long-term work in cold environments
7) Social history: None
8) Family history: None
9) Medications and Treatments Applied: Nutritional deficiencies and dehydration due to severe imbalanced diet
- Patient B
1) Name: Kim O O (F/84)
2) Diagnosis: Xerotic eczema, dry skin
3) Date of Onset: Several decades ago
4) Treatment Duration: March 2022 ~ November 2022
5) Primary Symptoms: Cracking at the fingertips and toes, pain, numbness, onychomycosis
6) Medical history: Frostbite, frequent exposure to cold environments
7) Social history: None
8) Family history: None
9) Medications and Treatments Applied: Hypertension, antihistamines, topical steroids, knee pain medication, Donepezil 5mg tablets
Detailed OCNT prescriptions for each patient are shown in Table 1 and Table 2.
Table 1 . OCNT Prescription Details for Patient A.
Type / Duration | 1 month | 2 months | 3 months | 4 months | Remarks |
---|---|---|---|---|---|
Cyaplex A granules | 101 | 101 | 101 | 101 | - |
NO booster capsule | 202 | 202 | 202 | 202 | |
Hemoplex capsule | 202 | 202 | 202 | 202 | |
Eufaplex Alpha stick | - | 101 | 101 | 101 | |
Diverol capsule | - | 101 | 101 | 101 | |
Cyaplex balm | Apply a suitable amount to the affected area 2-3 times a day. | ||||
Heartberry black | 1 packet per day | 1 packet per day | 1 packet per day | 1 packet per day | Dilute the above prescription in 1L of water for divided doses |
Cyaplex mineral bamboo salt | 1 packet per day | 1 packet per day | 1 packet per day | 1 packet per day | |
Aqua SAC pure | 1 packet per day | 1 packet per day | 1 packet per day | 1 packet per day |
* 101: Twice a day, one capsule/packet per dose; 202: Twice a day, two capsules/packets per dose.
Table 2 . OCNT Prescription Details for Patient B.
Type / Duration | 1 month | 2 months | 3 months | 4 months | 5~9 months |
---|---|---|---|---|---|
Cyaplex X granules | 101 | 101 | 101 | 101 | 101 |
NO booster capsule | 101 | 101 | 202 | 202 | 202 |
Viva circu capsule | 101 | 101 | 101 | 101 | 101 |
Caroplex capsule | - | - | 202 | 202 | 202 |
Sulfoplex PK tablet | 404 | 404 | 404 | 404 | 404 |
Sulfoplex cream | Apply a suitable amount to the affected area 2-3 times a day. |
* 101: Twice a day, one capsule/packet per dose; 202: Twice a day, two capsules/packets per dose; 404: Twice a day, four capsules/packets per dose.
Patient A indicated a cracking on the backs of the hands, thinning of the facial skin, and severe dryness in the ears. Other reported issues were leg numbness and dizziness. After one month of applying OCNT, there was significant improvement in leg numbness and dizziness, suggesting a good adaptation to OCNT. Therefore, OCNT was continued with an increased variety of prescriptions. After four months of treatment, not only were the primary symptoms of dry skin and scaling significantly improved, but also the attending physician determined that proper moisturizing care alone would be sufficient. The severity of symptoms experienced by Patient A during OCNT is detailed in Table 3.
Table 3 . Symptom Severity During OCNT for Patient A.
Symptom / Duration | 1 month | 2 months | 3 months | 4 months |
---|---|---|---|---|
Skin dryness | 5 | 3 | 2 | 1 |
Scale | 4 | 3 | 2 | 0 |
Lower limb numbness | 4 | 2 | 1 | 0 |
Dizziness | 4 | 2 | 1 | 0 |
0: No symptoms, no interference with daily life; 1: Mild symptoms, almost no effect on daily life; 2: Moderate symptoms, some discomfort in daily life; 3: Significant symptoms, discomfort in performing some activities; 4: Severe symptoms, great difficulty in daily activities; 5: Symptoms make activities almost impossible, causing significant daily discomfort.
In the case of Patient B, symptoms included cracking at the fingertips and toes, numbness, and pain at the affected sites, along with joint pain and fatigue. Although the skin had become hardened with scales and cracks, gradual improvement in symptoms appeared two months after starting OCNT. The prescription was continued to suit the patient, and by the fifth month, the symptoms had almost completely disappeared. The severity of symptoms experienced by Patient B during OCNT is detailed in Table 4.
Table 4 . Symptom Severity During OCNT for Patient B.
Symptom / Duration | 1 month | 2 months | 3 months | 4 months | 5~9 months |
---|---|---|---|---|---|
Skin dryness | 5 | 3 | 1 | 1 | 0 |
Splitting of fingertips and toes | 5 | 4 | 2 | 1 | 0 |
Pain | 5 | 4 | 2 | 0 | 0 |
Numbness | 4 | 2 | 0 | 0 | 0 |
Fatigue | 4 | 2 | 1 | 1 | 1 |
0: No symptoms, no interference with daily life; 1: Mild symptoms, almost no effect on daily life; 2: Moderate symptoms, some discomfort in daily life; 3: Significant symptoms, discomfort in performing some activities; 4: Severe symptoms, great difficulty in daily activities; 5: Symptoms make activities almost impossible, causing significant daily discomfort.
Patient A, a woman in her 60s, frequently exposed to cold environments, experienced frostbite and continued to suffer similar symptoms due to repeated exposure to cold work environments. This led to thinning of the facial skin, persistent skin dryness, and erythema. Whenever the symptoms worsened, she applied steroids and moisturizing topical agents sporadically, which provided only temporary relief.
Patient B, a woman in her 80s, initially suffered frostbite while washing clothes by a cold stream in her youth and subsequently endured prolonged exposure to cold environments, leading to chronic and entrenched symptoms of scaling and cracking in her hands and feet. This patient also used symptomatic medications and long-term topical steroids, which failed to show significant improvement. Therefore, both patients underwent OCNT to address the underlying causes.
Both patients shared common experiences of frostbite and frequent exposure to cold environments, which likely triggered and sustained their symptoms. This exposure weakened their antioxidant function and led to eczema becoming entrenched due to aging-related immune decline.
The anthocyanins abundantly present in Cyaplex reduce oxidative stress, thereby enhancing antioxidant capabilities. They also decrease the expression of inflammatory markers TNF-α and IL-1β, aiding in immune activation. Particularly, anthocyanins extracted from Aronia have been reported to exhibit superior antioxidant effectiveness compared to those extracted from other berries or plants.6
Additionally, zinc plays a role in regulating immune responses through its bioavailability, which is controlled by various transporters and regulatory factors. Manganese acts as a co-factor for numerous enzymes and plays a crucial role in regulating immune responses and neural activities. Deficiencies in these nutrients can lead to decreased immune function and increased inflammation.7,8 Therefore, both patients were supplemented with zinc and manganese through NO booster to enhance their immune capabilities and reduce inflammatory responses.
Patient A, a woman in her 60s, had suffered from severe picky eating, leading to nutritional imbalances and chronic dehydration. As a result, the use of steroidal drugs and moisturizing external agents was only effective as a temporary remedy. Additionally, OCNT was prescribed to address her symptoms of lower limb numbness and dizziness.
Omega-3, Eufaplex's main ingredient, has been reported to have anti-inflammatory effects on various skin conditions, including psoriasis and atopic dermatitis.9 Moreover, lanolin contained in Cyaplex balm, a substance secreted by sheep sebaceous glands, is extensively used to alleviate symptoms associated with dry skin in the elderly.10
A deficiency in iron can lead to dry and rough skin, paleness, and dizziness due to inadequate oxygen supply in the body.11 Therefore, Hemoplex was used to provide sufficient heme iron to help alleviate both the patient’s skin symptoms and dizziness. Additionally, Diverol was administered to supply Vitamin D, which possesses strong immunomodulatory properties. Deficiency in this nutrient can lead to symptoms such as numbness commonly associated with rheumatoid arthritis and myopathy.12
Patient B consistently reported numbness and pain in affected areas when exposed to cold environments. Additionally, her pre-existing hypertension likely contributed to circulatory issues, limiting the effectiveness of drug treatments. Therefore, a tailored OCNT was prescribed to alleviate these issues.
Sulfoplex, containing Methylsulfonylmethane (MSM), provides sulfur necessary for the synthesis of skin health-related substances like collagen and hyaluronic acid. Studies have shown that MSM intake can reduce wrinkles and skin roughness compared to a placebo.13 It also affects various mechanisms such as regulating the expression of RUNX2, an upstream signal of SP7 that controls the expression of various bone formation genes, contributing to joint protection.14 Since Patient B was already taking medication for knee pain, both the oral Sulfoplex PK tablet and the topical Sulfoplex cream were applied to manage her skin symptoms and joint pain simultaneously.
Viva circu, containing ginkgo biloba extract, has been known for its antioxidant properties, with numerous studies showing improved blood flow in groups receiving ginkgo biloba extract.15 Additionally, the various carotenoids in Caroplex have been shown to reduce fatigue perception as intake increases.16 The components ingested through OCNT were used to enhance the body's internal circulation and reduce fatigue.
As described above, the tailored OCNT led to significant improvements in the eczema symptoms of each patient. Particularly, both patients, being elderly and having suffered symptoms for many years, showed significant alleviation of discomfort, which is considered highly meaningful.
This case study has limitations in universally applying to all patients with xerotic eczema. However, the significant improvement in eczema symptoms and overall quality of life through tailored OCNT is deemed meaningful. The report is made with the patient's consent.
CellMed 2024; 14(9): 2.1-2.4
Published online July 31, 2024 https://doi.org/10.5667/CellMed.spc.089
Copyright © Cellmed Orthocellular Medicine and Pharmaceutical Association.
조종빈 약사
전라남도 화순군 화순읍 자치샘로 42-2 셀메드화순종로약국
Pharmacist, Jong-Bin Jo
Cellmed Hwasun Jongro Pharmacy, 42-2, Jachisam-ro, Hwasun-eup, Hwasun-gun, Jeonllanam-do, Republic of Korea
Correspondence to:Jong-Bin Jo
E-mail: jongro3720178@hanmail.net
☨ This report has been translated and edited by the CellMed editor-in-chief, Prof. Beom-Jin Lee.
This is an open access article under the CC BY-NC license. (http://creativecommons.org/licenses/by-nc/3.0/)
Objective: A case report on the improvement of xerotic eczema through Ortho-Cellular Nutrition Therapy (OCNT).
Methods: OCNT was administered to Korean women in their 60s and 70s who had been experiencing xerotic eczema for several years to decades.
Results: After the application of OCNT, there was a significant improvement in the symptoms of xerotic eczema and individual symptoms the patients had.
Conclusion: The application of OCNT can help alleviate symptoms in patients with xerotic eczema.
Keywords: Ortho-Cellular Nutrition Therapy (OCNT), xerotic eczema, frostbite, cold environments
Xerotic eczema refers to eczema that occurs when the skin is dry. This symptom often occurs between autumn and spring, especially during the mostly dry winter season, hence it is also called "winter eczema." It occurs frequently in young people but is predominantly found in the elderly.1
The symptoms of xerotic eczema include dryness, skin cracking, excessive scaling, redness, erythema, pain, etc. Scales, in this case, may cause the dry skin to rise like 'cracked pottery' or 'a dry riverbed'.2 Occasionally, the skin may thicken or hyperpigmentation may occur. These symptoms mainly develop on the arms and legs, particularly the shins, and also frequently occur on exposed areas such as the nose, ears, and face.
Xerotic eczema is often caused by decreased lipids on the surface of the skin consisting of the lipid layer, dermis, and epidermis or by functional skin disorders. In such cases, increased moisture loss through the epidermis from the stratum corneum decreases the skin's moisture content. This situation causes the epidermis to contract and leads to excessive scaling and itching.3
These symptoms can occur when exposed to cold and dry environments for extended periods. Conversely, they can be exacerbated by using too hot water and harsh cleansers for showering or bathing without moisturizing afterward.1 Therefore, it is crucial to reduce behaviors that may irritate the skin and to manage humidity and moisturize using oily lotions.4
Despite these preventive measures, when xerotic eczema does occur, it can be treated with oral medications, topical steroids, and antihistamines.4 However, most treatments rely on symptomatic relief, and prolonged use of steroids can lead to increased infection risks, skin atrophy, and delayed wound healing, necessitating caution in their prescription and use.5
This case study targeted two patients who had long-standing xerotic eczema and exhibited significant improvement of symptoms following Ortho-Cellular Nutrition Therapy (OCNT).
Two cases of xerotic eczema, referred to as Patient A and Patient B.
- Patient A
1) Name: Jung O (F/61)
2) Diagnosis: Xerotic eczema, dry skin
3) Date of Onset: Several years ago
4) Treatment Duration: February 2022 ~ June 2022
5) Primary Symptoms: Cracking on the backs of the hands, thinning facial skin, dryness in the ears, leg numbness, dizziness
6) Medical history: Frostbite, long-term work in cold environments
7) Social history: None
8) Family history: None
9) Medications and Treatments Applied: Nutritional deficiencies and dehydration due to severe imbalanced diet
- Patient B
1) Name: Kim O O (F/84)
2) Diagnosis: Xerotic eczema, dry skin
3) Date of Onset: Several decades ago
4) Treatment Duration: March 2022 ~ November 2022
5) Primary Symptoms: Cracking at the fingertips and toes, pain, numbness, onychomycosis
6) Medical history: Frostbite, frequent exposure to cold environments
7) Social history: None
8) Family history: None
9) Medications and Treatments Applied: Hypertension, antihistamines, topical steroids, knee pain medication, Donepezil 5mg tablets
Detailed OCNT prescriptions for each patient are shown in Table 1 and Table 2.
Table 1 . OCNT Prescription Details for Patient A..
Type / Duration | 1 month | 2 months | 3 months | 4 months | Remarks |
---|---|---|---|---|---|
Cyaplex A granules | 101 | 101 | 101 | 101 | - |
NO booster capsule | 202 | 202 | 202 | 202 | |
Hemoplex capsule | 202 | 202 | 202 | 202 | |
Eufaplex Alpha stick | - | 101 | 101 | 101 | |
Diverol capsule | - | 101 | 101 | 101 | |
Cyaplex balm | Apply a suitable amount to the affected area 2-3 times a day. | ||||
Heartberry black | 1 packet per day | 1 packet per day | 1 packet per day | 1 packet per day | Dilute the above prescription in 1L of water for divided doses |
Cyaplex mineral bamboo salt | 1 packet per day | 1 packet per day | 1 packet per day | 1 packet per day | |
Aqua SAC pure | 1 packet per day | 1 packet per day | 1 packet per day | 1 packet per day |
* 101: Twice a day, one capsule/packet per dose; 202: Twice a day, two capsules/packets per dose..
Table 2 . OCNT Prescription Details for Patient B..
Type / Duration | 1 month | 2 months | 3 months | 4 months | 5~9 months |
---|---|---|---|---|---|
Cyaplex X granules | 101 | 101 | 101 | 101 | 101 |
NO booster capsule | 101 | 101 | 202 | 202 | 202 |
Viva circu capsule | 101 | 101 | 101 | 101 | 101 |
Caroplex capsule | - | - | 202 | 202 | 202 |
Sulfoplex PK tablet | 404 | 404 | 404 | 404 | 404 |
Sulfoplex cream | Apply a suitable amount to the affected area 2-3 times a day. |
* 101: Twice a day, one capsule/packet per dose; 202: Twice a day, two capsules/packets per dose; 404: Twice a day, four capsules/packets per dose..
Patient A indicated a cracking on the backs of the hands, thinning of the facial skin, and severe dryness in the ears. Other reported issues were leg numbness and dizziness. After one month of applying OCNT, there was significant improvement in leg numbness and dizziness, suggesting a good adaptation to OCNT. Therefore, OCNT was continued with an increased variety of prescriptions. After four months of treatment, not only were the primary symptoms of dry skin and scaling significantly improved, but also the attending physician determined that proper moisturizing care alone would be sufficient. The severity of symptoms experienced by Patient A during OCNT is detailed in Table 3.
Table 3 . Symptom Severity During OCNT for Patient A..
Symptom / Duration | 1 month | 2 months | 3 months | 4 months |
---|---|---|---|---|
Skin dryness | 5 | 3 | 2 | 1 |
Scale | 4 | 3 | 2 | 0 |
Lower limb numbness | 4 | 2 | 1 | 0 |
Dizziness | 4 | 2 | 1 | 0 |
0: No symptoms, no interference with daily life; 1: Mild symptoms, almost no effect on daily life; 2: Moderate symptoms, some discomfort in daily life; 3: Significant symptoms, discomfort in performing some activities; 4: Severe symptoms, great difficulty in daily activities; 5: Symptoms make activities almost impossible, causing significant daily discomfort..
In the case of Patient B, symptoms included cracking at the fingertips and toes, numbness, and pain at the affected sites, along with joint pain and fatigue. Although the skin had become hardened with scales and cracks, gradual improvement in symptoms appeared two months after starting OCNT. The prescription was continued to suit the patient, and by the fifth month, the symptoms had almost completely disappeared. The severity of symptoms experienced by Patient B during OCNT is detailed in Table 4.
Table 4 . Symptom Severity During OCNT for Patient B..
Symptom / Duration | 1 month | 2 months | 3 months | 4 months | 5~9 months |
---|---|---|---|---|---|
Skin dryness | 5 | 3 | 1 | 1 | 0 |
Splitting of fingertips and toes | 5 | 4 | 2 | 1 | 0 |
Pain | 5 | 4 | 2 | 0 | 0 |
Numbness | 4 | 2 | 0 | 0 | 0 |
Fatigue | 4 | 2 | 1 | 1 | 1 |
0: No symptoms, no interference with daily life; 1: Mild symptoms, almost no effect on daily life; 2: Moderate symptoms, some discomfort in daily life; 3: Significant symptoms, discomfort in performing some activities; 4: Severe symptoms, great difficulty in daily activities; 5: Symptoms make activities almost impossible, causing significant daily discomfort..
Patient A, a woman in her 60s, frequently exposed to cold environments, experienced frostbite and continued to suffer similar symptoms due to repeated exposure to cold work environments. This led to thinning of the facial skin, persistent skin dryness, and erythema. Whenever the symptoms worsened, she applied steroids and moisturizing topical agents sporadically, which provided only temporary relief.
Patient B, a woman in her 80s, initially suffered frostbite while washing clothes by a cold stream in her youth and subsequently endured prolonged exposure to cold environments, leading to chronic and entrenched symptoms of scaling and cracking in her hands and feet. This patient also used symptomatic medications and long-term topical steroids, which failed to show significant improvement. Therefore, both patients underwent OCNT to address the underlying causes.
Both patients shared common experiences of frostbite and frequent exposure to cold environments, which likely triggered and sustained their symptoms. This exposure weakened their antioxidant function and led to eczema becoming entrenched due to aging-related immune decline.
The anthocyanins abundantly present in Cyaplex reduce oxidative stress, thereby enhancing antioxidant capabilities. They also decrease the expression of inflammatory markers TNF-α and IL-1β, aiding in immune activation. Particularly, anthocyanins extracted from Aronia have been reported to exhibit superior antioxidant effectiveness compared to those extracted from other berries or plants.6
Additionally, zinc plays a role in regulating immune responses through its bioavailability, which is controlled by various transporters and regulatory factors. Manganese acts as a co-factor for numerous enzymes and plays a crucial role in regulating immune responses and neural activities. Deficiencies in these nutrients can lead to decreased immune function and increased inflammation.7,8 Therefore, both patients were supplemented with zinc and manganese through NO booster to enhance their immune capabilities and reduce inflammatory responses.
Patient A, a woman in her 60s, had suffered from severe picky eating, leading to nutritional imbalances and chronic dehydration. As a result, the use of steroidal drugs and moisturizing external agents was only effective as a temporary remedy. Additionally, OCNT was prescribed to address her symptoms of lower limb numbness and dizziness.
Omega-3, Eufaplex's main ingredient, has been reported to have anti-inflammatory effects on various skin conditions, including psoriasis and atopic dermatitis.9 Moreover, lanolin contained in Cyaplex balm, a substance secreted by sheep sebaceous glands, is extensively used to alleviate symptoms associated with dry skin in the elderly.10
A deficiency in iron can lead to dry and rough skin, paleness, and dizziness due to inadequate oxygen supply in the body.11 Therefore, Hemoplex was used to provide sufficient heme iron to help alleviate both the patient’s skin symptoms and dizziness. Additionally, Diverol was administered to supply Vitamin D, which possesses strong immunomodulatory properties. Deficiency in this nutrient can lead to symptoms such as numbness commonly associated with rheumatoid arthritis and myopathy.12
Patient B consistently reported numbness and pain in affected areas when exposed to cold environments. Additionally, her pre-existing hypertension likely contributed to circulatory issues, limiting the effectiveness of drug treatments. Therefore, a tailored OCNT was prescribed to alleviate these issues.
Sulfoplex, containing Methylsulfonylmethane (MSM), provides sulfur necessary for the synthesis of skin health-related substances like collagen and hyaluronic acid. Studies have shown that MSM intake can reduce wrinkles and skin roughness compared to a placebo.13 It also affects various mechanisms such as regulating the expression of RUNX2, an upstream signal of SP7 that controls the expression of various bone formation genes, contributing to joint protection.14 Since Patient B was already taking medication for knee pain, both the oral Sulfoplex PK tablet and the topical Sulfoplex cream were applied to manage her skin symptoms and joint pain simultaneously.
Viva circu, containing ginkgo biloba extract, has been known for its antioxidant properties, with numerous studies showing improved blood flow in groups receiving ginkgo biloba extract.15 Additionally, the various carotenoids in Caroplex have been shown to reduce fatigue perception as intake increases.16 The components ingested through OCNT were used to enhance the body's internal circulation and reduce fatigue.
As described above, the tailored OCNT led to significant improvements in the eczema symptoms of each patient. Particularly, both patients, being elderly and having suffered symptoms for many years, showed significant alleviation of discomfort, which is considered highly meaningful.
This case study has limitations in universally applying to all patients with xerotic eczema. However, the significant improvement in eczema symptoms and overall quality of life through tailored OCNT is deemed meaningful. The report is made with the patient's consent.
Table 1 . OCNT Prescription Details for Patient A..
Type / Duration | 1 month | 2 months | 3 months | 4 months | Remarks |
---|---|---|---|---|---|
Cyaplex A granules | 101 | 101 | 101 | 101 | - |
NO booster capsule | 202 | 202 | 202 | 202 | |
Hemoplex capsule | 202 | 202 | 202 | 202 | |
Eufaplex Alpha stick | - | 101 | 101 | 101 | |
Diverol capsule | - | 101 | 101 | 101 | |
Cyaplex balm | Apply a suitable amount to the affected area 2-3 times a day. | ||||
Heartberry black | 1 packet per day | 1 packet per day | 1 packet per day | 1 packet per day | Dilute the above prescription in 1L of water for divided doses |
Cyaplex mineral bamboo salt | 1 packet per day | 1 packet per day | 1 packet per day | 1 packet per day | |
Aqua SAC pure | 1 packet per day | 1 packet per day | 1 packet per day | 1 packet per day |
* 101: Twice a day, one capsule/packet per dose; 202: Twice a day, two capsules/packets per dose..
Table 2 . OCNT Prescription Details for Patient B..
Type / Duration | 1 month | 2 months | 3 months | 4 months | 5~9 months |
---|---|---|---|---|---|
Cyaplex X granules | 101 | 101 | 101 | 101 | 101 |
NO booster capsule | 101 | 101 | 202 | 202 | 202 |
Viva circu capsule | 101 | 101 | 101 | 101 | 101 |
Caroplex capsule | - | - | 202 | 202 | 202 |
Sulfoplex PK tablet | 404 | 404 | 404 | 404 | 404 |
Sulfoplex cream | Apply a suitable amount to the affected area 2-3 times a day. |
* 101: Twice a day, one capsule/packet per dose; 202: Twice a day, two capsules/packets per dose; 404: Twice a day, four capsules/packets per dose..
Table 3 . Symptom Severity During OCNT for Patient A..
Symptom / Duration | 1 month | 2 months | 3 months | 4 months |
---|---|---|---|---|
Skin dryness | 5 | 3 | 2 | 1 |
Scale | 4 | 3 | 2 | 0 |
Lower limb numbness | 4 | 2 | 1 | 0 |
Dizziness | 4 | 2 | 1 | 0 |
0: No symptoms, no interference with daily life; 1: Mild symptoms, almost no effect on daily life; 2: Moderate symptoms, some discomfort in daily life; 3: Significant symptoms, discomfort in performing some activities; 4: Severe symptoms, great difficulty in daily activities; 5: Symptoms make activities almost impossible, causing significant daily discomfort..
Table 4 . Symptom Severity During OCNT for Patient B..
Symptom / Duration | 1 month | 2 months | 3 months | 4 months | 5~9 months |
---|---|---|---|---|---|
Skin dryness | 5 | 3 | 1 | 1 | 0 |
Splitting of fingertips and toes | 5 | 4 | 2 | 1 | 0 |
Pain | 5 | 4 | 2 | 0 | 0 |
Numbness | 4 | 2 | 0 | 0 | 0 |
Fatigue | 4 | 2 | 1 | 1 | 1 |
0: No symptoms, no interference with daily life; 1: Mild symptoms, almost no effect on daily life; 2: Moderate symptoms, some discomfort in daily life; 3: Significant symptoms, discomfort in performing some activities; 4: Severe symptoms, great difficulty in daily activities; 5: Symptoms make activities almost impossible, causing significant daily discomfort..
Pharmacist, Young Mi Ha
CellMed 2024; 14(11): 4.1-4.3Pharmacist, Jong-Bin Jo
CellMed 2024; 14(11): 3.1-3.4Pharmacist, Minho Baek
CellMed 2024; 14(11): 2.1-2.4